We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
(-43%)
Cap. Flow
-$786M
Cap. Flow
% of AUM
-52.7%
Top 10 Holdings %
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$10.5M |
| 2 |
iShares MSCI India ETF
INDA
|
+$9.67M |
| 3 |
IBKC
IBERIABANK Corp
IBKC
|
+$8.93M |
| 4 |
BlackRock Corporate High Yield Fund
HYT
|
+$8.03M |
| 5 |
Amazon
AMZN
|
+$7.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$16.7M |
| 2 |
Netflix
NFLX
|
+$15.8M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$15.7M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$15.1M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.31% |
| 2 | Consumer Discretionary | 3.94% |
| 3 | Healthcare | 3.91% |
| 4 | Communication Services | 2.7% |
| 5 | Financials | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
1001
DELISTED
Invacare Corporation
IVC
| $19K | ﹤0.01% |
2,579
-664
| -20% | -$5.14K |
|
|
VIVO
1002
DELISTED
Meridian Bioscience Inc
VIVO
| $19K | ﹤0.01% |
2,224
+2,201
| +9,570% | +$18.5K |
|
|
EGOV
1003
DELISTED
NIC Inc
EGOV
| $19K | ﹤0.01% |
831
-33,769
| -98% | -$689K |
|
|
CLCT
1004
DELISTED
Collectors Universe
CLCT
| $19K | ﹤0.01% |
1,192
-3,566
| -75% | -$79.7K |
|
1005
AES
AES
$10.5B
| $18K | ﹤0.01% |
1,295
+975
| +305% | +$17.5K |
|
1006
Blackbaud
BLKB
$2.06B
| $18K | ﹤0.01% |
+329
| New | +$23.3K |
|
1007
Cogent Communications
CCOI
$554M
| $18K | ﹤0.01% |
220
-15
| -6% | -$1.13K |
|
1008
Costamare
CMRE
$1.69B
| $18K | ﹤0.01% |
+4,003
| New | +$28.7K |
|
1009
Hartford Financial Services
HIG
$38.1B
| $18K | ﹤0.01% |
514
-5,995
| -92% | -$312K |
|
1010
Ligand Pharmaceuticals
LGND
$5.76B
| $18K | ﹤0.01% |
404
-303
| -43% | -$17.2K |
|
|
TWO
1011
Two Harbors Investment
TWO
$1.26B
| $18K | ﹤0.01% |
1,157
-451
| -28% | -$23K |
|
|
WCC
1012
CALL
WESCO International
WCC
$17.8B
| $18K | ﹤0.01% |
800
+600
| +300% | +$25.6K |
|
|
SIVB
1013
DELISTED
SVB Financial Group
SIVB
| $18K | ﹤0.01% |
+118
| New | +$26K |
|
1014
Coca-Cola Europacific Partners
CCEP
$47.1B
| $17K | ﹤0.01% |
+450
| New | +$21.9K |
|
1015
Cohu
COHU
$2.5B
| $17K | ﹤0.01% |
1,333
+624
| +88% | +$12.7K |
|
1016
Coty
COTY
$2.48B
| $17K | ﹤0.01% |
3,327
-8,547
| -72% | -$80.2K |
|
1017
Copa Holdings
CPA
$5.49B
| $17K | ﹤0.01% |
383
+195
| +104% | +$16.7K |
|
1018
Carlisle Companies
CSL
$15.5B
| $17K | ﹤0.01% |
135
-793
| -85% | -$118K |
|
1019
CALL
DuPont de Nemours
DD
$19.5B
| $17K | ﹤0.01% |
+398
| New | +$24.4K |
|
1020
Hope Bancorp
HOPE
$1.82B
| $17K | ﹤0.01% |
2,104
+91
| +5% | +$1.14K |
|
1021
Nu Skin
NUS
$237M
| $17K | ﹤0.01% |
781
-567
| -42% | -$17.1K |
|
|
THS
1022
DELISTED
Treehouse Foods
THS
| $17K | ﹤0.01% |
389
-2,255
| -85% | -$97.1K |
|
|
GTS
1023
DELISTED
Triple-S Management Corporation
GTS
| $17K | ﹤0.01% |
1,183
-1,388
| -54% | -$22.4K |
|
1024
Applied Industrial Technologies
AIT
$13B
| $16K | ﹤0.01% |
+356
| New | +$21.1K |
|
|
AMRN
1025
CALL
Amarin Corp
AMRN
$296M
| $16K | ﹤0.01% |
205
-355
| -63% | -$118K |
|
Similar funds
PFBT
SP
HCS
SPC
GPCM
CC
MB
ACM
Prelude Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.
- Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
- Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
- Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
- Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
- Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
- Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
- Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.
Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.